Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 104 entries
Sorted by: Best Match Show Resources per page
Single dose cefazolin plus metronidazole versus existing multi-dose regimen for prophylaxis in caesarean section.

Indian journal of pharmacology

Pore SM, Sardesai SP, Tapare VS, Kulkarni MV, Malhotra AP, Chavan CS.
PMID: 22529497
Indian J Pharmacol. 2012 Mar;44(2):279-80. doi: 10.4103/0253-7613.93874.

No abstract available.

Cite
Pore SM, Sardesai SP, Tapare VS, et al. Single dose cefazolin plus metronidazole versus existing multi-dose regimen for prophylaxis in caesarean section. Indian J Pharmacol. 2012;44(2):279-80doi: 10.4103/0253-7613.93874.
Pore, S. M., Sardesai, S. P., Tapare, V. S., Kulkarni, M. V., Malhotra, A. P., & Chavan, C. S. (2012). Single dose cefazolin plus metronidazole versus existing multi-dose regimen for prophylaxis in caesarean section. Indian journal of pharmacology, 44(2), 279-80. https://doi.org/10.4103/0253-7613.93874
Pore, Shraddha M, et al. "Single dose cefazolin plus metronidazole versus existing multi-dose regimen for prophylaxis in caesarean section." Indian journal of pharmacology vol. 44,2 (2012): 279-80. doi: https://doi.org/10.4103/0253-7613.93874
Pore SM, Sardesai SP, Tapare VS, Kulkarni MV, Malhotra AP, Chavan CS. Single dose cefazolin plus metronidazole versus existing multi-dose regimen for prophylaxis in caesarean section. Indian J Pharmacol. 2012 Mar;44(2):279-80. doi: 10.4103/0253-7613.93874. PMID: 22529497; PMCID: PMC3326934.
Copy Download .nbib Format: NLM
Benign cytic teratoma of ovary perforating into the urinary bladder: a rare case.

Journal of obstetrics and gynaecology of India

Sardesai S, Raghoji V, Dabade R, Shaikh H.
PMID: 24293876
J Obstet Gynaecol India. 2012 Dec;62:54-5. doi: 10.1007/s13224-013-0354-x. Epub 2013 Mar 12.

No abstract available.

Cite
Sardesai S, Raghoji V, Dabade R, et al. Benign cytic teratoma of ovary perforating into the urinary bladder: a rare case. J Obstet Gynaecol India. 2013;62:54-5doi: 10.1007/s13224-013-0354-x.
Sardesai, S., Raghoji, V., Dabade, R., & Shaikh, H. (2012). Benign cytic teratoma of ovary perforating into the urinary bladder: a rare case. Journal of obstetrics and gynaecology of India, 6254-5. https://doi.org/10.1007/s13224-013-0354-x
Sardesai, Suman, et al. "Benign cytic teratoma of ovary perforating into the urinary bladder: a rare case." Journal of obstetrics and gynaecology of India vol. 62 (2012): 54-5. doi: https://doi.org/10.1007/s13224-013-0354-x
Sardesai S, Raghoji V, Dabade R, Shaikh H. Benign cytic teratoma of ovary perforating into the urinary bladder: a rare case. J Obstet Gynaecol India. 2012 Dec;62:54-5. doi: 10.1007/s13224-013-0354-x. Epub 2013 Mar 12. PMID: 24293876; PMCID: PMC3632703.
Copy Download .nbib Format: NLM
Transorbital neuroendoscopic management of sinogenic complications involving the frontal sinus, orbit, and anterior cranial fossa.

Journal of neurological surgery. Part B, Skull base

Lim JH, Sardesai MG, Ferreira M, Moe KS.
PMID: 24294556
J Neurol Surg B Skull Base. 2012 Dec;73(6):394-400. doi: 10.1055/s-0032-1329617. Epub 2012 Nov 15.

Transnasal endoscopic surgery has remained at the forefront of surgical management of sinogenic complications involving the frontal sinus, orbit, and anterior skull base. However, the difficulty in accessing certain areas of these anatomical regions can potentially limit its use....

Cite
Lim JH, Sardesai MG, Ferreira M, et al. Transorbital neuroendoscopic management of sinogenic complications involving the frontal sinus, orbit, and anterior cranial fossa. J Neurol Surg B Skull Base. 2012;73(6):394-400doi: 10.1055/s-0032-1329617.
Lim, J. H., Sardesai, M. G., Ferreira, M., & Moe, K. S. (2012). Transorbital neuroendoscopic management of sinogenic complications involving the frontal sinus, orbit, and anterior cranial fossa. Journal of neurological surgery. Part B, Skull base, 73(6), 394-400. https://doi.org/10.1055/s-0032-1329617
Lim, Jae H, et al. "Transorbital neuroendoscopic management of sinogenic complications involving the frontal sinus, orbit, and anterior cranial fossa." Journal of neurological surgery. Part B, Skull base vol. 73,6 (2012): 394-400. doi: https://doi.org/10.1055/s-0032-1329617
Lim JH, Sardesai MG, Ferreira M, Moe KS. Transorbital neuroendoscopic management of sinogenic complications involving the frontal sinus, orbit, and anterior cranial fossa. J Neurol Surg B Skull Base. 2012 Dec;73(6):394-400. doi: 10.1055/s-0032-1329617. Epub 2012 Nov 15. PMID: 24294556; PMCID: PMC3578590.
Copy Download .nbib Format: NLM
Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation.

Vaccines

Cashman KA, Broderick KE, Wilkinson ER, Shaia CI, Bell TM, Shurtleff AC, Spik KW, Badger CV, Guttieri MC, Sardesai NY, Schmaljohn CS.
PMID: 26344112
Vaccines (Basel). 2013 Jul 18;1(3):262-77. doi: 10.3390/vaccines1030262.

Lassa virus (LASV) causes a severe, often fatal, hemorrhagic fever endemic to West Africa. Presently, there are no FDA-licensed medical countermeasures for this disease. In a pilot study, we constructed a DNA vaccine (pLASV-GPC) that expressed the LASV glycoprotein...

Cite
Cashman KA, Broderick KE, Wilkinson ER, et al. Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation. Vaccines (Basel). 2013;1(3):262-77doi: 10.3390/vaccines1030262.
Cashman, K. A., Broderick, K. E., Wilkinson, E. R., Shaia, C. I., Bell, T. M., Shurtleff, A. C., Spik, K. W., Badger, C. V., Guttieri, M. C., Sardesai, N. Y., & Schmaljohn, C. S. (2013). Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation. Vaccines, 1(3), 262-77. https://doi.org/10.3390/vaccines1030262
Cashman, Kathleen A, et al. "Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation." Vaccines vol. 1,3 (2013): 262-77. doi: https://doi.org/10.3390/vaccines1030262
Cashman KA, Broderick KE, Wilkinson ER, Shaia CI, Bell TM, Shurtleff AC, Spik KW, Badger CV, Guttieri MC, Sardesai NY, Schmaljohn CS. Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation. Vaccines (Basel). 2013 Jul 18;1(3):262-77. doi: 10.3390/vaccines1030262. PMID: 26344112; PMCID: PMC4494234.
Copy Download .nbib Format: NLM
Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab.

Indian journal of dermatology

Sardesai VV, Sardesai VR, Agarwal TD.
PMID: 25657435
Indian J Dermatol. 2015 Jan-Feb;60(1):106. doi: 10.4103/0019-5154.147874.

Systemic Lupus Erythematosus (SLE) is a multisystem disorder characterized by production of numerous autoantibodies, some of which have pathogenic consequences and result in considerable morbidity. Herein, we present a case of 48-year-old female with SLE having autoimmune hemolytic anemia,...

Cite
Sardesai VV, Sardesai VR, Agarwal TD. Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab. Indian J Dermatol. 2015;60(1):106doi: 10.4103/0019-5154.147874.
Sardesai, V. V., Sardesai, V. R., & Agarwal, T. D. (2015). Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab. Indian journal of dermatology, 60(1), 106. https://doi.org/10.4103/0019-5154.147874
Sardesai, Vasudha V, et al. "Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab." Indian journal of dermatology vol. 60,1 (2015): 106. doi: https://doi.org/10.4103/0019-5154.147874
Sardesai VV, Sardesai VR, Agarwal TD. Steroid-resistant autoimmune thrombocytopenia in systemic lupus erythematosus treated with rituximab. Indian J Dermatol. 2015 Jan-Feb;60(1):106. doi: 10.4103/0019-5154.147874. PMID: 25657435; PMCID: PMC4318041.
Copy Download .nbib Format: NLM
Double Cross Plasty for Management of Transverse Vaginal Septum: A 20-Year Retrospective Review of Our Experience.

Journal of obstetrics and gynaecology of India

Sardesai SP, Dabade R, Chitale V.
PMID: 26085740
J Obstet Gynaecol India. 2015 May;65(3):181-5. doi: 10.1007/s13224-014-0542-3. Epub 2014 Jun 27.

OBJECTIVES: Evaluation of double cross plasty for management of obstructive or non obstructive transverse vaginal septum.METHODS: 13 patients presented either as cryptomenorrhoea or as infertility/dyspareunia were diagnosed to have transverse vaginal septum. They were subjected to double cross plasty...

Cite
Sardesai SP, Dabade R, Chitale V. Double Cross Plasty for Management of Transverse Vaginal Septum: A 20-Year Retrospective Review of Our Experience. J Obstet Gynaecol India. 2014;65(3):181-5doi: 10.1007/s13224-014-0542-3.
Sardesai, S. P., Dabade, R., & Chitale, V. (2015). Double Cross Plasty for Management of Transverse Vaginal Septum: A 20-Year Retrospective Review of Our Experience. Journal of obstetrics and gynaecology of India, 65(3), 181-5. https://doi.org/10.1007/s13224-014-0542-3
Sardesai, Suman Pradeep, et al. "Double Cross Plasty for Management of Transverse Vaginal Septum: A 20-Year Retrospective Review of Our Experience." Journal of obstetrics and gynaecology of India vol. 65,3 (2015): 181-5. doi: https://doi.org/10.1007/s13224-014-0542-3
Sardesai SP, Dabade R, Chitale V. Double Cross Plasty for Management of Transverse Vaginal Septum: A 20-Year Retrospective Review of Our Experience. J Obstet Gynaecol India. 2015 May;65(3):181-5. doi: 10.1007/s13224-014-0542-3. Epub 2014 Jun 27. PMID: 26085740; PMCID: PMC4464565.
Copy Download .nbib Format: NLM
Predicting post-stroke motor recovery of upper extremity using clinical variables and performance assays: A prospective cohort study protocol.

Physiotherapy research international : the journal for researchers and clinicians in physical therapy

Sardesai S, Solomon M J, Arumugam A, Guddattu V, Gorthi SP, Pai A, Kumaran D S.
PMID: 35037341
Physiother Res Int. 2022 Jan 17;e1937. doi: 10.1002/pri.1937. Epub 2022 Jan 17.

BACKGROUND AND PURPOSE: Measurement of movement quality is essential to distinguish motor recovery patterns and optimize rehabilitation strategies post-stroke. Recently, the Stroke Recovery and Rehabilitation Roundtable Taskforce (SRRR) recommended four kinetic and kinematic performance assays to measure upper extremity...

Cite
Sardesai S, Solomon M J, Arumugam A, et al. Predicting post-stroke motor recovery of upper extremity using clinical variables and performance assays: A prospective cohort study protocol. Physiother Res Int. 2022;e1937doi: 10.1002/pri.1937.
Sardesai, S., Solomon M, J., Arumugam, A., Guddattu, V., Gorthi, S. P., Pai, A., & Kumaran D, S. (2022). Predicting post-stroke motor recovery of upper extremity using clinical variables and performance assays: A prospective cohort study protocol. Physiotherapy research international : the journal for researchers and clinicians in physical therapy, e1937. https://doi.org/10.1002/pri.1937
Sardesai, Sanjukta, et al. "Predicting post-stroke motor recovery of upper extremity using clinical variables and performance assays: A prospective cohort study protocol." Physiotherapy research international : the journal for researchers and clinicians in physical therapy vol. (2022): e1937. doi: https://doi.org/10.1002/pri.1937
Sardesai S, Solomon M J, Arumugam A, Guddattu V, Gorthi SP, Pai A, Kumaran D S. Predicting post-stroke motor recovery of upper extremity using clinical variables and performance assays: A prospective cohort study protocol. Physiother Res Int. 2022 Jan 17;e1937. doi: 10.1002/pri.1937. Epub 2022 Jan 17. PMID: 35037341.
Copy Download .nbib Format: NLM
A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study.

Journal of oncology

Zvinovski F, Stephens JA, Ramaswamy B, Reinbolt RE, Noonan AM, VanDeusen JB, Wesolowski R, Stover DG, Williams NO, Sardesai SD, Mehta L, Foraker R, Gulati M, Lustberg M, Quick AM.
PMID: 34135964
J Oncol. 2021 May 27;2021:9965583. doi: 10.1155/2021/9965583. eCollection 2021.

PURPOSE: The purpose of this study was to determine the feasibility and preliminary efficacy of a cardiac rehabilitation (CR) intervention in the breast cancer population.METHODS: This single-arm feasibility study evaluated a 14-week CR intervention program in breast cancer survivors....

Cite
Zvinovski F, Stephens JA, Ramaswamy B, et al. A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study. J Oncol. 2021;2021:9965583doi: 10.1155/2021/9965583.
Zvinovski, F., Stephens, J. A., Ramaswamy, B., Reinbolt, R. E., Noonan, A. M., VanDeusen, J. B., Wesolowski, R., Stover, D. G., Williams, N. O., Sardesai, S. D., Mehta, L., Foraker, R., Gulati, M., Lustberg, M., & Quick, A. M. (2021). A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study. Journal of oncology, 20219965583. https://doi.org/10.1155/2021/9965583
Zvinovski, Filadelfiya, et al. "A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study." Journal of oncology vol. 2021 (2021): 9965583. doi: https://doi.org/10.1155/2021/9965583
Zvinovski F, Stephens JA, Ramaswamy B, Reinbolt RE, Noonan AM, VanDeusen JB, Wesolowski R, Stover DG, Williams NO, Sardesai SD, Mehta L, Foraker R, Gulati M, Lustberg M, Quick AM. A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study. J Oncol. 2021 May 27;2021:9965583. doi: 10.1155/2021/9965583. eCollection 2021. PMID: 34135964; PMCID: PMC8178006.
Copy Download .nbib Format: NLM
Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC.

Clinical cancer research : an official journal of the American Association for Cancer Research

Sardesai SD, Thomas A, Gallagher C, Lynce F, Ottaviano YL, Ballinger TJ, Schneider BP, Storniolo AM, Bauchle A, Althouse SK, Perkins SM, Masters AR, Stratford RE, Dong Z, Liu JY, Zhang JT, Miller KD.
PMID: 34400413
Clin Cancer Res. 2021 Nov 01;27(21):5810-5817. doi: 10.1158/1078-0432.CCR-21-0493. Epub 2021 Aug 16.

PURPOSE: Fatty acid synthase (FASN) is overexpressed in 70% of operable triple-negative breast cancer (TNBC) and is associated with poor prognosis. Proton pump inhibitors selectively inhibit FASN activity and induce apoptosis in TNBC cell lines.PATIENTS AND METHODS: Patients with...

Cite
Sardesai SD, Thomas A, Gallagher C, et al. Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC. Clin Cancer Res. 2021;27(21):5810-5817doi: 10.1158/1078-0432.CCR-21-0493.
Sardesai, S. D., Thomas, A., Gallagher, C., Lynce, F., Ottaviano, Y. L., Ballinger, T. J., Schneider, B. P., Storniolo, A. M., Bauchle, A., Althouse, S. K., Perkins, S. M., Masters, A. R., Stratford, R. E., Dong, Z., Liu, J. Y., Zhang, J. T., & Miller, K. D. (2021). Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(21), 5810-5817. https://doi.org/10.1158/1078-0432.CCR-21-0493
Sardesai, Sagar D, et al. "Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,21 (2021): 5810-5817. doi: https://doi.org/10.1158/1078-0432.CCR-21-0493
Sardesai SD, Thomas A, Gallagher C, Lynce F, Ottaviano YL, Ballinger TJ, Schneider BP, Storniolo AM, Bauchle A, Althouse SK, Perkins SM, Masters AR, Stratford RE, Dong Z, Liu JY, Zhang JT, Miller KD. Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC. Clin Cancer Res. 2021 Nov 01;27(21):5810-5817. doi: 10.1158/1078-0432.CCR-21-0493. Epub 2021 Aug 16. PMID: 34400413.
Copy Download .nbib Format: NLM
Polytraumatized patient lower extremity nonunion development: Raw data.

Data in brief

Sardesai NR, Gaski GE, Gunderson ZJ, Cunningham CM, Slaven J, Meagher AD, McKinley TO, Natoli RM.
PMID: 34258338
Data Brief. 2021 Jun 25;37:107244. doi: 10.1016/j.dib.2021.107244. eCollection 2021 Aug.

In this article we report data collected to evaluate the pathomechanistic effect of acute anaerobic metabolism in the polytraumatized patient and its subsequent effect on fracture nonunion; see "Base Deficit ≥6 within 24 Hours of Injury is a Risk...

Cite
Sardesai NR, Gaski GE, Gunderson ZJ, et al. Polytraumatized patient lower extremity nonunion development: Raw data. Data Brief. 2021;37:107244doi: 10.1016/j.dib.2021.107244.
Sardesai, N. R., Gaski, G. E., Gunderson, Z. J., Cunningham, C. M., Slaven, J., Meagher, A. D., McKinley, T. O., & Natoli, R. M. (2021). Polytraumatized patient lower extremity nonunion development: Raw data. Data in brief, 37107244. https://doi.org/10.1016/j.dib.2021.107244
Sardesai, Neil R, et al. "Polytraumatized patient lower extremity nonunion development: Raw data." Data in brief vol. 37 (2021): 107244. doi: https://doi.org/10.1016/j.dib.2021.107244
Sardesai NR, Gaski GE, Gunderson ZJ, Cunningham CM, Slaven J, Meagher AD, McKinley TO, Natoli RM. Polytraumatized patient lower extremity nonunion development: Raw data. Data Brief. 2021 Jun 25;37:107244. doi: 10.1016/j.dib.2021.107244. eCollection 2021 Aug. PMID: 34258338; PMCID: PMC8253899.
Copy Download .nbib Format: NLM
An uncommon diagnosis of a common presentation of mass per rectum.

International journal of surgery case reports

Naik AS, Roshini AP, Sardesai V, Radhika Raj CG.
PMID: 32773293
Int J Surg Case Rep. 2020;74:277-280. doi: 10.1016/j.ijscr.2020.06.093. Epub 2020 Jun 26.

Introduction - In adults, protrusion of intussuscepted sigmoid growth through the anal canal is exceedingly rare, with only 9 cases being reported till date. Case Report - A 52-year old man presented to emergency department with what appeared to...

Cite
Naik AS, Roshini AP, Sardesai V, et al. An uncommon diagnosis of a common presentation of mass per rectum. Int J Surg Case Rep. 2020;74:277-280doi: 10.1016/j.ijscr.2020.06.093.
Naik, A. S., Roshini, A. P., Sardesai, V., & Radhika Raj, C. G. (2020). An uncommon diagnosis of a common presentation of mass per rectum. International journal of surgery case reports, 74277-280. https://doi.org/10.1016/j.ijscr.2020.06.093
Naik, Akshay Surendra, et al. "An uncommon diagnosis of a common presentation of mass per rectum." International journal of surgery case reports vol. 74 (2020): 277-280. doi: https://doi.org/10.1016/j.ijscr.2020.06.093
Naik AS, Roshini AP, Sardesai V, Radhika Raj CG. An uncommon diagnosis of a common presentation of mass per rectum. Int J Surg Case Rep. 2020;74:277-280. doi: 10.1016/j.ijscr.2020.06.093. Epub 2020 Jun 26. PMID: 32773293; PMCID: PMC7503787.
Copy Download .nbib Format: NLM
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer.

Cardio-oncology (London, England)

Sardesai S, Sukumar J, Kassem M, Palettas M, Stephens J, Morgan E, Addison D, Baliga R, Stover DG, VanDeusen J, Williams N, Cherian M, Lustberg M, Wesolowski R, Ramaswamy B.
PMID: 33292843
Cardiooncology. 2020 Nov 05;6(1):26. doi: 10.1186/s40959-020-00081-9.

BACKGROUND: Trastuzumab-induced cardiotoxicity (TIC) can lead to early discontinuation of adjuvant therapy, however there is limited evidence on long-term survival outcomes in patients with operable human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) experiencing treatment interruption or...

Cite
Sardesai S, Sukumar J, Kassem M, et al. Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer. Cardiooncology. 2020;6(1):26doi: 10.1186/s40959-020-00081-9.
Sardesai, S., Sukumar, J., Kassem, M., Palettas, M., Stephens, J., Morgan, E., Addison, D., Baliga, R., Stover, D. G., VanDeusen, J., Williams, N., Cherian, M., Lustberg, M., Wesolowski, R., & Ramaswamy, B. (2020). Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer. Cardio-oncology (London, England), 6(1), 26. https://doi.org/10.1186/s40959-020-00081-9
Sardesai, Sagar, et al. "Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer." Cardio-oncology (London, England) vol. 6,1 (2020): 26. doi: https://doi.org/10.1186/s40959-020-00081-9
Sardesai S, Sukumar J, Kassem M, Palettas M, Stephens J, Morgan E, Addison D, Baliga R, Stover DG, VanDeusen J, Williams N, Cherian M, Lustberg M, Wesolowski R, Ramaswamy B. Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer. Cardiooncology. 2020 Nov 05;6(1):26. doi: 10.1186/s40959-020-00081-9. PMID: 33292843; PMCID: PMC7643282.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 104 entries